ICD-10: E71.128

Other disorders of propionate metabolism

Additional Information

Description

The ICD-10 code E71.128 refers to "Other disorders of propionate metabolism," which encompasses a range of metabolic conditions related to the body's inability to properly process propionate, a byproduct of certain amino acids and fatty acids. Below is a detailed clinical description and relevant information regarding this condition.

Overview of Propionate Metabolism

Propionate metabolism is crucial for the breakdown of specific amino acids, particularly those that are branched-chain, as well as certain fatty acids. Disorders in this metabolic pathway can lead to the accumulation of toxic metabolites, resulting in various health complications. The body typically converts propionate into succinyl-CoA, which is then utilized in the Krebs cycle for energy production.

Clinical Presentation

Patients with disorders of propionate metabolism may present with a variety of symptoms, which can vary significantly depending on the specific disorder and its severity. Common clinical features include:

  • Metabolic Acidosis: Due to the accumulation of propionic acid, patients may experience metabolic acidosis, which can lead to symptoms such as lethargy, vomiting, and dehydration.
  • Neurological Symptoms: Some individuals may exhibit neurological manifestations, including developmental delays, seizures, or hypotonia (decreased muscle tone).
  • Failure to Thrive: Infants and young children may show poor growth and feeding difficulties, often leading to failure to thrive.
  • Acute Illness Episodes: Patients may experience acute metabolic crises triggered by illness, fasting, or high-protein diets, necessitating immediate medical intervention.

Types of Disorders Included

The category of "Other disorders of propionate metabolism" under E71.128 includes various specific conditions, such as:

  • Propionic Acidemia: A genetic disorder caused by a deficiency in the enzyme propionyl-CoA carboxylase, leading to the accumulation of propionic acid in the blood.
  • Propionyl-CoA Carboxylase Deficiency: This condition is characterized by a specific enzymatic defect that impairs the conversion of propionyl-CoA to methylmalonyl-CoA, resulting in metabolic disturbances.

Diagnosis

Diagnosis of disorders related to propionate metabolism typically involves:

  • Biochemical Testing: Blood and urine tests to measure levels of propionic acid and other metabolites.
  • Genetic Testing: Identification of specific genetic mutations associated with propionate metabolism disorders.
  • Clinical Evaluation: A thorough assessment of symptoms and family history to determine the likelihood of a metabolic disorder.

Management and Treatment

Management of disorders of propionate metabolism often includes:

  • Dietary Management: A low-protein diet may be recommended to reduce the intake of amino acids that lead to propionate production. Medical foods and supplements may also be utilized to ensure adequate nutrition.
  • Emergency Care: In cases of metabolic crisis, immediate medical treatment may be necessary, including intravenous fluids and medications to correct metabolic imbalances.
  • Long-term Monitoring: Regular follow-up with metabolic specialists to monitor growth, development, and metabolic status is essential for managing these conditions effectively.

Conclusion

ICD-10 code E71.128 encompasses a range of disorders related to propionate metabolism, each with unique clinical presentations and management strategies. Early diagnosis and intervention are critical to improving outcomes for affected individuals. Ongoing research and advancements in genetic testing continue to enhance our understanding of these metabolic disorders, paving the way for better treatment options and support for patients and families.

Treatment Guidelines

Disorders of propionate metabolism, classified under ICD-10 code E71.128, encompass a range of metabolic conditions that affect the body's ability to process propionic acid. These disorders can lead to a buildup of toxic substances in the body, resulting in various health complications. The management of these conditions typically involves a combination of dietary interventions, medical treatments, and supportive care. Below is a detailed overview of standard treatment approaches for these disorders.

Dietary Management

Low-Protein Diet

One of the primary treatment strategies for disorders of propionate metabolism is the implementation of a low-protein diet. This approach aims to reduce the intake of amino acids that can be converted into propionic acid. Patients are often advised to limit protein sources, particularly those high in branched-chain amino acids, which can exacerbate the condition[1].

Specialized Formulas

In some cases, patients may require specialized medical foods or formulas that are low in propionic acid precursors. These hydrolyzed enteral formulas are designed to provide essential nutrients while minimizing the risk of metabolic crises associated with propionate accumulation[2].

Nutritional Supplements

To ensure adequate nutrition while adhering to a restricted diet, patients may need to take specific nutritional supplements. These can include vitamins and minerals that are often deficient in low-protein diets, such as vitamin B12 and calcium[3].

Medical Management

Metabolic Crisis Management

Patients with propionate metabolism disorders may experience metabolic crises, which require immediate medical attention. During such episodes, treatment may involve intravenous fluids, glucose administration, and medications to manage symptoms and stabilize metabolic function[4].

Pharmacological Interventions

Certain medications may be prescribed to help manage symptoms or complications associated with propionate metabolism disorders. For instance, carnitine supplementation can aid in the removal of excess propionic acid from the body by enhancing fatty acid metabolism[5].

Monitoring and Supportive Care

Regular Monitoring

Ongoing monitoring of metabolic parameters is crucial for patients with disorders of propionate metabolism. This includes regular blood tests to assess levels of propionic acid and other metabolites, as well as monitoring for potential complications such as neurological issues or growth delays[6].

Genetic Counseling

Since many disorders of propionate metabolism are inherited, genetic counseling can be beneficial for affected individuals and their families. This can provide insights into the condition, its inheritance patterns, and implications for family planning[7].

Multidisciplinary Care

A multidisciplinary approach involving dietitians, metabolic specialists, and other healthcare providers is essential for comprehensive management. This team can work together to tailor treatment plans to the individual needs of the patient, ensuring optimal care and support[8].

Conclusion

The management of disorders of propionate metabolism, as indicated by ICD-10 code E71.128, requires a multifaceted approach that includes dietary modifications, medical treatments, and ongoing monitoring. By implementing these strategies, healthcare providers can help mitigate the risks associated with these metabolic disorders and improve the quality of life for affected individuals. Regular follow-ups and a supportive care network are vital to address the evolving needs of patients throughout their lives.

Diagnostic Criteria

The ICD-10 code E71.128 refers to "Other disorders of propionate metabolism," which encompasses a range of metabolic disorders related to the abnormal processing of propionate, a key intermediate in various metabolic pathways. Diagnosing these disorders typically involves a combination of clinical evaluation, biochemical testing, and genetic analysis. Below are the key criteria and methods used for diagnosis:

Clinical Evaluation

  1. Symptom Assessment: Patients may present with a variety of symptoms, including:
    - Developmental delays
    - Neurological issues (e.g., seizures, hypotonia)
    - Gastrointestinal disturbances (e.g., vomiting, feeding difficulties)
    - Metabolic crises, particularly during periods of stress or illness

  2. Family History: A detailed family history is crucial, as many propionate metabolism disorders are inherited in an autosomal recessive manner. A family history of similar metabolic disorders can provide important diagnostic clues.

Biochemical Testing

  1. Plasma Amino Acids: Elevated levels of certain amino acids, particularly propionylcarnitine, can indicate a disorder of propionate metabolism. This is often assessed through tandem mass spectrometry.

  2. Urine Organic Acids: Analysis of urine for organic acids can reveal the presence of abnormal metabolites, such as propionic acid, which is typically elevated in individuals with propionic acidemia, a specific type of disorder under this category.

  3. Acylcarnitine Profile: A blood test measuring acylcarnitines can help identify specific metabolic defects. In disorders of propionate metabolism, there may be an accumulation of propionylcarnitine.

Genetic Testing

  1. Molecular Genetic Testing: Identification of mutations in genes associated with propionate metabolism, such as the PCCA and PCCB genes, is essential for confirming the diagnosis. Genetic testing can provide definitive evidence of a metabolic disorder.

  2. Enzyme Activity Assays: In some cases, measuring the activity of propionyl-CoA carboxylase (the enzyme involved in propionate metabolism) in fibroblasts or other tissues can help confirm a diagnosis.

Differential Diagnosis

It is important to differentiate between various disorders of propionate metabolism, as they can present with similar clinical features. Conditions such as propionic acidemia, methylmalonic acidemia, and other related metabolic disorders must be considered during the diagnostic process.

Conclusion

The diagnosis of disorders related to propionate metabolism, classified under ICD-10 code E71.128, involves a comprehensive approach that includes clinical assessment, biochemical testing, and genetic analysis. Early diagnosis is crucial for managing symptoms and preventing metabolic crises, which can significantly impact the patient's quality of life. If you suspect a disorder of propionate metabolism, consulting a metabolic specialist is recommended for further evaluation and management.

Approximate Synonyms

ICD-10 code E71.128 refers to "Other disorders of propionate metabolism," which encompasses a range of metabolic conditions related to the body's inability to properly process propionate, a byproduct of certain amino acids and fatty acids. Here are some alternative names and related terms associated with this condition:

Alternative Names

  1. Propionic Acidemia: This is the most common term used to describe a specific disorder characterized by the accumulation of propionic acid in the body due to a deficiency in the enzyme propionyl-CoA carboxylase.
  2. Propionate Metabolism Disorder: A broader term that can refer to any disorder affecting the metabolism of propionate, including but not limited to propionic acidemia.
  3. Methylmalonic Acidemia: While primarily associated with a different metabolic pathway, some forms of methylmalonic acidemia can involve propionate metabolism, leading to overlapping symptoms and metabolic disturbances.
  4. Propionyl-CoA Carboxylase Deficiency: This term specifically refers to the enzyme deficiency that leads to propionic acidemia and related disorders.
  1. Inherited Metabolic Disorders: A category that includes various genetic conditions affecting metabolism, including disorders of propionate metabolism.
  2. Organic Acidemias: A group of metabolic disorders characterized by the accumulation of organic acids in the body, which includes propionic acidemia.
  3. Amino Acid Metabolism Disorders: Since propionate is derived from certain amino acids, disorders in this category may also relate to propionate metabolism.
  4. Fatty Acid Oxidation Disorders: Some conditions affecting fatty acid metabolism can also impact propionate levels, leading to related metabolic issues.

Conclusion

Understanding the alternative names and related terms for ICD-10 code E71.128 is crucial for healthcare professionals and researchers working in the field of metabolic disorders. These terms help in identifying, diagnosing, and managing conditions associated with propionate metabolism effectively. If you need further information on specific disorders or their management, feel free to ask!

Clinical Information

The ICD-10 code E71.128 refers to "Other disorders of propionate metabolism," which encompasses a range of metabolic disorders characterized by the body's inability to properly metabolize propionate, a short-chain fatty acid. These disorders can lead to various clinical presentations, signs, symptoms, and patient characteristics. Below is a detailed overview of these aspects.

Clinical Presentation

Patients with disorders of propionate metabolism typically present with a variety of symptoms that can vary in severity and onset. The clinical presentation often depends on the specific disorder and the age of onset. Commonly, these disorders manifest in infancy or early childhood, but some cases may present later in life.

Signs and Symptoms

  1. Neurological Symptoms:
    - Developmental Delays: Children may exhibit delays in reaching developmental milestones, such as walking or speaking.
    - Seizures: Neurological disturbances, including seizures, are common due to metabolic imbalances.
    - Hypotonia: Reduced muscle tone can be observed, affecting motor skills.

  2. Gastrointestinal Symptoms:
    - Vomiting: Frequent vomiting can occur, particularly during metabolic crises.
    - Poor Feeding: Infants may have difficulty feeding, leading to failure to thrive.

  3. Metabolic Symptoms:
    - Acidosis: Metabolic acidosis may develop due to the accumulation of organic acids, leading to symptoms such as lethargy and confusion.
    - Hypoglycemia: Low blood sugar levels can occur, resulting in irritability and weakness.

  4. Other Symptoms:
    - Foul-smelling urine: Some patients may have distinctive odors in their urine due to the presence of specific metabolites.
    - Skin Rashes: Dermatological manifestations can occur, although they are less common.

Patient Characteristics

Demographics

  • Age: Disorders of propionate metabolism often present in infancy or early childhood, but some forms may not be diagnosed until later in life.
  • Genetic Background: These disorders are typically inherited in an autosomal recessive pattern, meaning that both parents must carry a copy of the mutated gene for a child to be affected.

Family History

  • A family history of metabolic disorders may be present, as many of these conditions are genetic. Genetic counseling is often recommended for families with a history of propionate metabolism disorders.

Laboratory Findings

  • Elevated Propionate Levels: Laboratory tests may reveal elevated levels of propionate and other related metabolites in blood and urine.
  • Organic Acids in Urine: Urine organic acid analysis can show specific patterns indicative of propionate metabolism disorders.

Conclusion

Disorders of propionate metabolism, classified under ICD-10 code E71.128, present a complex clinical picture characterized by a range of neurological, gastrointestinal, and metabolic symptoms. Early diagnosis and management are crucial to mitigate the potential complications associated with these disorders. Genetic counseling and metabolic monitoring are essential components of care for affected individuals and their families. If you suspect a disorder of propionate metabolism, it is important to consult a healthcare professional for appropriate testing and intervention.

Related Information

Description

Treatment Guidelines

  • Low-protein diet reduces propionic acid production
  • Specialized formulas minimize metabolic crises risk
  • Nutritional supplements ensure adequate nutrition
  • Intravenous fluids manage metabolic crisis symptoms
  • Medications like carnitine aid in excess acid removal
  • Regular monitoring assesses metabolic parameters
  • Genetic counseling informs family planning decisions

Diagnostic Criteria

  • Developmental delays
  • Neurological issues (seizures, hypotonia)
  • Gastrointestinal disturbances (vomiting, feeding difficulties)
  • Metabolic crises during stress or illness
  • Elevated plasma amino acids (propionylcarnitine)
  • Abnormal urine organic acids (propionic acid)
  • Accumulation of propionylcarnitine in blood test
  • Identification of PCCA and PCCB gene mutations
  • Propionyl-CoA carboxylase enzyme activity assays

Approximate Synonyms

  • Propionic Acidemia
  • Propionate Metabolism Disorder
  • Methylmalonic Acidemia
  • Propionyl-CoA Carboxylase Deficiency
  • Inherited Metabolic Disorders
  • Organic Acidemias
  • Amino Acid Metabolism Disorders
  • Fatty Acid Oxidation Disorders

Clinical Information

  • Developmental delays in infants
  • Seizures due to metabolic imbalances
  • Hypotonia affects motor skills
  • Frequent vomiting during crises
  • Poor feeding leading to failure to thrive
  • Metabolic acidosis with lethargy and confusion
  • Hypoglycemia causing irritability and weakness
  • Foul-smelling urine due to specific metabolites
  • Skin rashes as a dermatological manifestation

Related Diseases

obsolete carbohydrate metabolism disease Danon disease Farber lipogranulomatosis Donohue syndrome Gamstorp-Wohlfart syndrome hypermethioninemia obsolete Majewski syndrome ABCD syndrome triple-A syndrome acrodermatitis enteropathica Bamforth-Lazarus syndrome Birk-Barel syndrome Bjornstad syndrome Borjeson-Forssman-Lehmann syndrome Bowen-Conradi syndrome Brody myopathy Brown-Vialetto-Van Laere syndrome vitamin metabolic disorder PSAT deficiency Chanarin-Dorfman syndrome Qazi Markouizos syndrome ARC syndrome obsolete Opitz-GBBB syndrome Ogden syndrome guanidinoacetate methyltransferase deficiency Kahrizi syndrome orotic aciduria Perrault syndrome Marshall-Smith syndrome IMAGe syndrome spastic ataxia 3 spastic ataxia 4 Charlevoix-Saguenay spastic ataxia autosomal recessive cerebellar ataxia hypomyelinating leukoencephalopathy alpha chain disease organic acidemia succinic semialdehyde dehydrogenase deficiency Warburg micro syndrome Van Maldergem syndrome MASA syndrome pontocerebellar hypoplasia type 2B pontocerebellar hypoplasia type 2C pontocerebellar hypoplasia type 5 omodysplasia Ohdo syndrome Ohdo syndrome, SBBYS variant Rapp-Hodgkin syndrome CEDNIK syndrome Stormorken syndrome Vici syndrome Galloway-Mowat syndrome 1 Cole-Carpenter syndrome lysinuric protein intolerance Desbuquois dysplasia EAST syndrome 3MC syndrome 2 3MC syndrome 3 Yunis-Varon syndrome Nance-Horan syndrome alpha-methylacyl-CoA racemase deficiency Wilson-Turner syndrome Miles-Carpenter syndrome Christianson syndrome Griscelli syndrome type 1 Griscelli syndrome type 3 Pierson syndrome

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.